Most recent news

8 April

2016

Firm news

Marcus Sims awarded two prizes from Chartered Institute of Patent Attorneys (CIPA)

Boult Wade Tennant is delighted to share that a trainee patent attorney, Marcus Sims, has recently been awarded prizes from the Chartered Institute of Patent Attorneys (CIPA) in acknowledgement of his outstanding examination results. Marcus is part of the Chemical and Materials Group which is recognised in the industry for their depth of knowledge and... right arrow

5 April

2016

Firm news

Tier one UK firm, Boult Wade Tennant, has announced the appointment of Jason Rutt

Tier one UK firm, Boult Wade Tennant, has announced the appointment of Jason Rutt, who has joined the firm’s Biotechnology and Life Sciences Group, as a Patent Attorney. The appointment is not only a reflection of the continuous growth of this group but clearly demonstrates the firm’s commitment to maintain its market-leading position. The biotechnology... right arrow

9 March

2016

Firm news

Boult Wade Tennant ranked top tier for Patents in MIP’s IP Stars Handbook

Managing Intellectual Property (MIP) has once again ranked Boult Wade Tennant in the top tier of its 2016 annual survey for patents. MIP’s IP Stars rankings is one of the most authoritative and comprehensive surveys of the IP legal market. They conduct months of extensive research that covers 80 countries; interviewing thousands of intellectual property... right arrow

4 February

2016

Firm news

Boult Wade Tennant ranked top tier for Trade Mark in MIP’s IP Stars Handbook

We are delighted to announce that Managing Intellectual Property (MIP) has ranked our trade mark practice in the top tier of its 2016 annual survey. MIP’s IP Stars rankings are based on extensive research among thousands of intellectual property practitioners from around the globe, creating one of the most comprehensive and authoritative surveys of the IP... right arrow

26 January

2016

Firm news

Rachel Conroy provides case comment for Pharma und Marke (PuM)

Read Rachel Conroy’s latest article published on the upcoming online blog and magazine Pharma und Marke (PuM). Here she examines the UKIPO’s decision, made late last year, in Glaxo Group Ltd versus Evonik Industries AG (Case O-587/15). This case, tackling the issue of likelihood of confusion, is of particular interest as the Hearing Officer takes... right arrow

1 24 25 26 27 28 40